Aprea Therapeutics, Inc. (APRE)

Operating Expenses

$4.03M

Quarterly · Period ending: · USD

APRE logo

APRE Operating Expenses

Latest reported$4.03M
APRE Quarterly Operating Expenses ($2.93M → $4.03M)
High-resolution chart · PNG

APRE operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
4,032,180
3,424,984
2,643,093
3,117,388
1,593,671
1,764,978
1,072,776
1,605,238
1,850,819
1,929,866
1,643,316
1,719,715
1,698,712
3,365,961
2,120,222
3,082,618
91,653,922
8,074,875
7,828,679
9,430,411
9,997,582
10,189,681
14,223,402
12,234,305
14,480,915
11,872,590
11,979,758
7,218,355
5,938,415
4,407,770
4,899,370
2,930,724
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.